Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Apply
ASTX727, Venetoclax, Ivosidenib, Enasidenib
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step